US5836705A
(en)
*
|
1992-07-27 |
1998-11-17 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and data entry and to ease transition from a qwerty keyboard
|
US5352050A
(en)
*
|
1992-07-27 |
1994-10-04 |
Choate John I M |
Keyboard arrangement to maximize typing speed and ease of transition from a QWERTY keyboard
|
US5498088A
(en)
*
|
1992-07-27 |
1996-03-12 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and ease of transition from a qwerty keyboard
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
AR002976A1
(es)
*
|
1995-03-31 |
1998-05-27 |
Lilly Co Eli |
Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
|
AU6299596A
(en)
*
|
1995-06-30 |
1997-02-05 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
ATE208208T1
(de)
*
|
1996-06-20 |
2001-11-15 |
Novo Nordisk As |
Halogenid-enthaltende insulinzubereitungen
|
PE79099A1
(es)
*
|
1997-06-13 |
1999-08-24 |
Lilly Co Eli |
Formulaciones de insulina estables
|
IL134901A0
(en)
|
1997-10-24 |
2001-05-20 |
Lilly Co Eli |
Insoluble insulin compositions
|
CO4970787A1
(es)
*
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
DE69924232D1
(de)
*
|
1998-01-09 |
2005-04-21 |
Novo Nordisk As |
Stabilisierte insulin-zubereitungen
|
US6211144B1
(en)
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
KR100617286B1
(ko)
*
|
1998-10-16 |
2006-08-30 |
노보 노르디스크 에이/에스 |
폐 송달을 위한 안정한 농축 인슐린 조제물
|
EP1121145B1
(fr)
*
|
1998-10-16 |
2002-04-17 |
Novo Nordisk A/S |
Preparations d'insuline contenant du menthol et destinees a l'administration par voie pulmonaire
|
US6635617B1
(en)
|
1998-10-16 |
2003-10-21 |
Novo Nordisk A/S |
Insulin preparations for pulmonary delivery containing menthol
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
EP1131089B1
(fr)
*
|
1998-11-18 |
2004-02-18 |
Novo Nordisk A/S |
Preparations stables d'insuline aqueuse sans phenol ni cresol
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
WO2001052937A1
(fr)
|
2000-01-24 |
2001-07-26 |
Medtronic Minimed, Inc. |
Systeme tampon melange pour la stabilisation de preparations pour polypeptides
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
JP2004536018A
(ja)
*
|
2000-07-31 |
2004-12-02 |
バル・イラン・ユニバーシティ |
創傷治療のための方法および薬学的組成物
|
DE10114178A1
(de)
*
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6737401B2
(en)
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
ES2664189T3
(es)
|
2002-01-09 |
2018-04-18 |
Emisphere Technologies, Inc. |
Polimorfos de 4-(4-cloro-2-hidroxibenzoil)aminobutanoato de sodio
|
US20030211976A1
(en)
*
|
2002-03-07 |
2003-11-13 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin formulation
|
US20040005999A1
(en)
*
|
2002-03-07 |
2004-01-08 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin preparation
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
US20060258561A1
(en)
*
|
2003-03-13 |
2006-11-16 |
Novo Nordisk A/S |
Novel NPH insulin preparations
|
ES2313018T3
(es)
|
2003-06-17 |
2009-03-01 |
Sembiosys Genetics Inc. |
Procedimiento de produccion de insulina en plantas.
|
ES2328579T3
(es)
*
|
2003-07-25 |
2009-11-16 |
Conjuchem Biotechnologies Inc. |
Derivados de insulina de larga duracion y procedimientos asociados.
|
EP1711220A1
(fr)
*
|
2004-01-16 |
2006-10-18 |
Biodel, Inc. |
Dispositif d'administration sublinguale de medicaments
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
AU2005240213B8
(en)
|
2004-05-06 |
2011-10-20 |
Emisphere Technologies, Inc. |
Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
|
MXPA06013251A
(es)
*
|
2004-05-14 |
2007-02-28 |
Emisphere Tech Inc |
Compuestos y composiciones de aril-cetona para suministrar agentes activos.
|
EP1750674A4
(fr)
*
|
2004-05-27 |
2012-05-23 |
Advanced Bionutrition Corp |
Microparticules pour administration orale
|
UA91512C2
(ru)
|
2004-07-19 |
2010-08-10 |
Биокон Лимитед |
Коньюгати олигомеров инсулина, их композиция (варианты) и применение
|
CN101014360A
(zh)
*
|
2004-08-03 |
2007-08-08 |
埃米斯菲尔技术公司 |
抗糖尿病口服胰岛素-双胍组合物
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US20060078623A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Emisphere Technologies, Inc. |
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
|
SI2918286T1
(sl)
*
|
2004-10-05 |
2020-06-30 |
Novo Nordisk A/S |
Farmacevtski pripravek, ki vsebuje inzulin v kristalni obliki in tudi v obliki raztopine
|
ES2391776T3
(es)
|
2004-11-22 |
2012-11-29 |
Novo Nordisk A/S |
Formulaciones solubles, estables conteniendo insulina con una sal de protamina
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
JPWO2006093222A1
(ja)
*
|
2005-03-02 |
2008-08-07 |
味の素株式会社 |
インスリンの多量体形成阻害剤
|
CA2625674C
(fr)
|
2005-08-29 |
2015-04-14 |
Healor Ltd. |
Methodes et compositions de prevention et de traitement de la peau diabetique et du vieillissement cutane
|
AR058053A1
(es)
*
|
2005-09-19 |
2008-01-23 |
Toole Doris C O |
Formas cristalinas polimorficas de la sal de di- sodio del acido n- (5 -clorosaliciloil)-8- aminocaprilico
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
EP1991575A1
(fr)
*
|
2006-02-21 |
2008-11-19 |
Novo Nordisk A/S |
Analogues d'insuline à chaîne unique et formules pharmaceutiques contenant lesdits analogues
|
MX2008013165A
(es)
|
2006-04-12 |
2009-01-29 |
Biodel Inc |
Formulaciones de combinacion de insulina de accion rapida y accion larga.
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
ES2554773T3
(es)
|
2006-10-04 |
2015-12-23 |
Case Western Reserve University |
Insulina y análogos de la insulina resistentes a la fibrilación
|
PL2134351T3
(pl)
|
2007-03-13 |
2017-10-31 |
Jds Therapeutics Llc |
Sposoby i kompozycje do przedłużonego uwalniania chromu
|
JP5526018B2
(ja)
*
|
2007-03-21 |
2014-06-18 |
エミスフェアー・テクノロジーズ・インク |
アリルオキシおよびアルキルオキシ安息香酸送達薬剤
|
EP2514412A1
(fr)
*
|
2007-04-30 |
2012-10-24 |
Novo Nordisk A/S |
Solutions et compositions d'insuline fortement concentrée
|
WO2009002867A2
(fr)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Forme posologique à unités multiples contenant un agent thérapeutique en combinaison avec un complément alimentaire
|
US9241908B2
(en)
|
2007-10-16 |
2016-01-26 |
Biocon Limited |
Orally administrable solid pharmaceutical composition and a process thereof
|
MX2010004716A
(es)
|
2007-11-02 |
2010-12-17 |
Emisphere Tech Inc |
Metodo para tratar la deficiencia de vitamina b12.
|
BRPI0916560A2
(pt)
|
2008-07-31 |
2015-11-10 |
Univ Case Western Reserve |
análogo de insulina, ácido nucléico, vetor de expressão, célula hospedeira e método de tratamento de um paciente.
|
ES2477552T3
(es)
|
2008-09-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
|
KR101820024B1
(ko)
|
2008-10-17 |
2018-01-18 |
사노피-아벤티스 도이칠란트 게엠베하 |
인슐린과 glp-1 효능제의 병용물
|
KR20110082180A
(ko)
|
2008-10-28 |
2011-07-18 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
알데히드 탈수소효소의 조절자 및 그것의 사용방법
|
MA33064B1
(fr)
|
2009-01-28 |
2012-02-01 |
Smartcells Inc |
Systemes à base de conjugués pour administration contrôlée de médicaments
|
WO2010088286A1
(fr)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Conjugués synthétiques et leurs utilisations
|
WO2010092218A2
(fr)
|
2009-02-12 |
2010-08-19 |
Proyecto De Biomedicina Cima, S.L. |
Utilisation de la cardiotrophine-1 pour le traitement de maladies métaboliques
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
AU2010226243A1
(en)
|
2009-03-20 |
2011-09-22 |
Smartcells, Inc. |
Terminally-functionalized conjugates and uses thereof
|
EP3345593B1
(fr)
|
2009-11-13 |
2023-09-06 |
Sanofi-Aventis Deutschland GmbH |
Composition pharmaceutique comprenant despro36exendin-4(1-39)-lys6-nh2 et de la méthionine
|
TR201809460T4
(tr)
|
2009-11-13 |
2018-07-23 |
Sanofi Aventis Deutschland |
Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
|
EP2523677A2
(fr)
|
2010-01-11 |
2012-11-21 |
Healor Ltd. |
Procédé pour traiter une maladie et un trouble inflammatoires
|
WO2011106378A2
(fr)
*
|
2010-02-24 |
2011-09-01 |
Emisphere Technologies, Inc. |
Thérapie orale à la vitamine b12
|
ES2606554T3
(es)
|
2010-08-30 |
2017-03-24 |
Sanofi-Aventis Deutschland Gmbh |
Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
|
CN103261181A
(zh)
|
2010-09-30 |
2013-08-21 |
索尔维公司 |
天然来源的环氧氯丙烷的衍生物
|
WO2012115641A1
(fr)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Compositions de pro-insuline lis-pro et procédés de production d'analogues d'insuline lis-pro à partir de celles-ci
|
CN105749253A
(zh)
|
2011-03-01 |
2016-07-13 |
Jds治疗有限公司 |
用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
TWI608847B
(zh)
|
2011-08-29 |
2017-12-21 |
賽諾菲阿凡提斯德意志有限公司 |
用於控制糖尿病二型病患血糖的醫藥組合物
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
BR112014010139A2
(pt)
|
2011-10-27 |
2017-04-25 |
Univ Case Western Reserve |
formulação farmacêutica, método de redução do nível de açúcar no sangue de um paciente e polipeptídeo
|
US10159735B2
(en)
*
|
2012-06-26 |
2018-12-25 |
The Curators Of The University Of Missouri |
Photocleavable drug conjugates
|
WO2014015078A1
(fr)
|
2012-07-17 |
2014-01-23 |
Michael Weiss |
Analogues de l'insuline modifiés par un glucide relié à l'oxygène
|
KR20150082640A
(ko)
|
2012-11-13 |
2015-07-15 |
아도시아 |
치환된 음이온성 화합물을 포함하는 속효성 인슐린 제형
|
US9707276B2
(en)
|
2012-12-03 |
2017-07-18 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
|
JP6111475B2
(ja)
|
2012-12-19 |
2017-04-12 |
ウォックハート リミテッド |
ヒトインスリン又はその類似体もしくは誘導体を含む安定な水性組成物
|
CN104870469A
(zh)
|
2012-12-26 |
2015-08-26 |
沃克哈特有限公司 |
药物组合物
|
JP6410790B2
(ja)
|
2013-03-14 |
2018-10-24 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法
|
TW201605489A
(zh)
|
2013-10-25 |
2016-02-16 |
賽諾菲公司 |
賴谷胰島素(insulin glulisine)的穩定調配物
|
WO2016032869A1
(fr)
|
2014-08-26 |
2016-03-03 |
Merck Sharp & Dohme Corp. |
Procédé de préparation de compositions d'analogue d'insuline ou d'insuline cristallines
|
PE20171622A1
(es)
|
2014-12-12 |
2017-11-02 |
Sanofi Aventis Deutschland |
Formulacion de relacion fija de insulina glargina/lixisenatida
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
US11865121B2
(en)
|
2016-02-11 |
2024-01-09 |
Nutrition21, LLC |
Chromium containing compositions for improving health and fitness
|
MA50496A
(fr)
|
2017-06-01 |
2020-09-09 |
Lilly Co Eli |
Compositions d'insuline à action rapide
|
EP3727424A4
(fr)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Systèmes à base de conjugués pour l'administration contrôlée d'insuline
|
EP3740212A4
(fr)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Systèmes à base de conjugués pour l'administration contrôlée d'insuline
|
CA3157995A1
(fr)
|
2019-10-25 |
2021-04-29 |
Cercacor Laboratories, Inc. |
Composes indicateurs, dispositifs comprenant des composes indicateurs, et leurs procedes de fabrication et d'utilisation
|
BR112022019687A2
(pt)
|
2020-03-31 |
2022-12-20 |
Protomer Tech Inc |
Conjugados para responsividade seletiva a dióis vicinais
|
JP2024500284A
(ja)
|
2020-11-19 |
2024-01-09 |
プロトマー・テクノロジーズ・インコーポレイテッド |
芳香族ホウ素含有化合物及びインスリン類似体
|
TW202409070A
(zh)
|
2022-05-18 |
2024-03-01 |
美商普羅托莫科技公司 |
芳族含硼化合物及相關胰島素類似物
|